High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma

NCT01237951 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Myeloma

Interventions

DRUG: Palifermin
DRUG: Dexamethasone
DRUG: Gemcitabine
DRUG: Busulfan
DRUG: Melphalan
PROCEDURE: Stem Cell Transplant
DRUG: G-CSF

Sponsor

M.D. Anderson Cancer Center